TIP 19: Detoxification From Alcohol and Other Drugs: Treatment

197 Pages·2009·1.52 MB·English

by  Alicia Fayne

TIP 19: Detoxification From Alcohol and
Other Drugs: Treatment Improvement
Protocol (TIP) Series 19
A39784
Donald R. Wesson, M.D.
Consensus Panel Chair
U.S. Department of Health and Human Services
Public Health Service
Substance Abuse and Mental Health Services Administration
Center for Substance Abuse Treatment
Rockwall II, 5600 Fishers Lane
Rockville, MD 20857
DHHS Publication No. (SMA) 95-3046
Printed 1995.
Disclaimer
This publication is part of the Substance Abuse Prevention and Treatment Block Grant technical
assistance program. All material appearing in this volume except quoted passages from
copyrighted sources is in the public domain and may be reproduced or copied without permission
from the Center for Substance Abuse Treatment (CSAT) or the authors. Citation of the source is
appreciated.
This publication was written under contract number ADM 270-91-0007 from the Center for
Substance Abuse Treatment of the Substance Abuse and Mental Health Services Administration
(SAMHSA). Sandra Clunies, M.S., served as the CSAT Government project officer. Dorynne
Czechowicz, M.D., served as the Government content advisor. Carolyn Davis, Betsy Earp, Jo
Lane Gregory-Thomas, Linda Harteker, Lise Markl, and Gail Martin served as writers.
The opinions expressed herein are the views of the consensus panel members and do not reflect
the official position of CSAT or any other part of the U.S. Department of Health and Human
Services (DHHS). No official support or endorsement of CSAT or DHHS for these opinions or for
particular instruments or software that may be described in this document is intended or should
be inferred. The guidelines proffered in this document should not be considered as substitutes for
individualized patient care and treatment decisions.
What Is a TIP?
CSAT Treatment Improvement Protocols (TIPs) are prepared by the Quality Assurance and
Evaluation Branch to facilitate the transfer of state-of-the-art protocols and guidelines for the
treatment of alcohol and other drug (AOD) abuse from acknowledged clinical, research, and
administrative experts to the Nation's AOD abuse treatment resources.
The dissemination of a TIP is the last step in a process that begins with the recommendation of
an AOD abuse problem area for consideration by a panel of experts. These include clinicians,
researchers, and program managers, as well as professionals in such related fields as social
services or criminal justice.
Once a topic has been selected, CSAT creates a Federal resource panel, with members from
pertinent Federal agencies and national organizations, to review the state of the art in treatment
and program management in the area selected. Recommendations from this Federal panel are
then transmitted to the members of a second group, which consists of non-Federal experts who
are intimately familiar with the topic. This group, known as a non-Federal consensus panel,
meets in Washington for 5 days, makes recommendations, defines protocols, and arrives at
agreement on protocols. Its members represent AOD abuse treatment programs, hospitals,
community health centers, counseling programs, criminal justice and child welfare agencies, and
private practitioners. A chair for the panel is charged with responsibility for ensuring that the
resulting protocol reflects true group consensus.
The next step is a review of the proposed guidelines and protocol by a third group whose
members serve as expert field reviewers. Once their recommendations and responses have been
reviewed, the chair approves the document for publication. The result is a TIP reflecting the
actual state of the art of AOD abuse treatment in public and private programs recognized for
their provision of high-quality and innovative AOD abuse treatment.
This TIP, Detoxification From Alcohol and Other Drugs, describes detoxification care in a number
of settings. Detoxification and patient matching are discussed. The TIP provides clinical
guidelines for detoxification from specific classes of drugs such as sedative-hypnotics, stimulants,
and opiates. Detoxification needs of special populations are addressed. The TIP also includes
information helpful to planners and policymakers about costs, quality improvement, outcome
criteria, health care reform, and linking detoxification -- often the gateway to ongoing treatment
-- to the larger continuum of care in the substance abuse treatment system. Legal and ethical
issues of concern to detoxification programs are also examined.
This TIP represents another step by CSAT toward its goal of bringing national leadership to bear
in the effort to improve AOD abuse treatment.
Other TIPs may be ordered by contacting the National Clearinghouse for Alcohol and Drug
Information (NCADI), [phone] or [phone]; TDD (for hearing impaired), (800)
487-4889).
Contents
Consensus Panel
Foreword
Chapter 1—Introduction
Chapter 2—Detoxification Settings and Patient Matching
Chapter 3—Clinical Detoxification Protocols
Chapter 4—Special Populations
Chapter 5—Improving Quality and Measuring Outcomes of AOD Detoxification
Services
Chapter 6—Costs and Current Payment Mechanisms for AOD Detoxification
Appendix A -- Bibliography
Appendix B—Glossary
Appendix C—Resource List
Appendix D—Acronyms
Appendix E - Legal and Ethical Issues for Detoxification Programs
Appendix F—Federal Resource Panel
Appendix G—Field Reviewers

TIP 19: Consensus Panel
Chair
Donald R. Wesson, M.D.
Scientific Director
MPI Treatment Services
Summit Medical Center
Oakland, California

Facilitators
Mary R. Haack, R.N., Ph.D.
Senior Research Scientist
Center for Health Policy Research
The George Washington University
Washington, D.C.

Karen Larson, R.N., B.S.N.
Assistant Director
Division of Alcohol and Drug Abuse
North Dakota Department of Human Services
Bismarck, North Dakota

Dorothy B. North, N.C.A.C. II, C.E.A.P.
Chief Executive Officer
Vitality Center
Elko, Nevada

Bonnie Baird Wilford, M.S.
Director
Pharmaceutical Policy Research Center
Intergovernmental Health Policy Project
The George Washington University
Washington, D.C.
Workgroup Members
Margaret Kent Brooks, J.D.
Consultant
Montclair, New Jersey

Margaret A. Compton, R.N., Ph.D.
Post-Doctoral Fellow
UCLA Drug Abuse Research Center
Neuropsychiatric Institute
Los Angeles, California

Archie S. Golden, M.D., M.P.H.
Director
Adolescent Substance Abuse Program and
Chairman
Department of Pediatrics
Johns Hopkins Bayview Medical Center
Baltimore, Maryland

Richard Harris, R.C.S.W.
Director of Housing and Chemical Dependency Services
Central City Concern
Portland, Oregon

Albert E. Jones, L.C.S.W.
Program Director
New Directions, Inc.
Memphis, Tennessee
Walter Ling, M.D.
Director
Los Angeles Addiction Treatment Research Center and
Associate Chief of Psychiatry for Substance Abuse
West Los Angeles Veterans Administration Medical Center and
Professor
Chief of Substance Abuse Program
University of California, Los Angeles (UCLA)
Los Angeles, California

Carole A. Madden, R.N., B.S.N., C.D.
Coordinator of Intervention Services
North Arundel Hospital
Glen Burnie, Maryland

John Melbourne, M.D.
Medical Director
Chemical Dependency Services
Danbury Hospital
Danbury, Connecticut
David E. Smith, M.D.
Medical Director
Haight Ashbury Free Clinics
Training and Education Project
San Francisco, California

Lovetta L. Smith, R.N., D.N.Sc., F.A.A.N. 1
Associate Chief of Nursing Service
Surgical and Special Care Service
Gainesville Veterans Administration Medical Center
Gainesville, Florida
Footnotes
1. Lovetta Smith, R.N., D.N.Sc., F.A.A.N., was originally cochair for this TIP but had to withdraw. Her
contributions as cochair are appreciated. Dr. Smith also served as a field reviewer for the document.

Foreword
The Treatment Improvement Protocol (TIP) series fulfills CSAT's mission to improve alcohol and
other drug (AOD) abuse and dependency treatment by providing best practices guidance to
clinicians, program administrators, and payers. This guidance, in the form of a protocol, results
from a careful consideration of all relevant clinical and health services research findings,
demonstration experience, and implementation requirements. A panel of non-Federal clinical
researchers, clinicians, program administrators, and patient advocates employs a consensus
process to produce the product. This panel's work is reviewed and critiqued by field reviewers as
it evolves.
The talent, dedication, and hard work that TIPs panelists and reviewers bring to this highly
participatory process have bridged the gap between the promise of research and the needs of
practicing clinicians and administrators. We are grateful to all who have joined with us to
contribute to advance our substance abuse treatment field.
Nelba Chavez, Ph.D.
Administrator
Substance Abuse and Mental Health Services Administration
David J. Mactas
Director
Center for Substance Abuse Treatment
TIP 19: Chapter 1—Introduction
The subject of this Center for Substance Abuse Treatment (CSAT) Treatment Improvement
Protocol (TIP) is alcohol and other drug (AOD) detoxification -- the process through which a
person who is physically dependent on alcohol, illegal drugs, prescription medications, or a
combination of these drugs is withdrawn from the drug or drugs of dependence. Since most
persons who have a substance use disorder are addicted to a combination of alcohol and/or
other drugs (polydrug abuse), detoxification often involves more than one substance.
This TIP was written by a panel composed of AOD specialists in detoxification -- physicians
specializing in addiction medicine, nurses, counselors, social workers, administrators, and
researchers. Their goal was to develop comprehensive guidelines that would be useful to single
State agency directors, physicians, nurses and other clinical staff, program administrators, staff
of insurance carriers and managed care organizations, policymakers, and other individuals
involved in planning, evaluating, and providing AOD detoxification services.
Panel members discussed detoxification settings and service components, and they reviewed
patient assessment techniques and current detoxification protocols, as well as experimental
treatments. They considered the needs of special populations; discussed issues related to
measuring program outcomes, program financing, and health care reform; and identified legal
and ethical issues of concern to program staff and administrators. This document reflects the
panelists' consensus on these issues and incorporates many suggestions and recommendations
from field reviewers.
Goals of Detoxification
The term detoxification implies a clearing of toxins (Alling, 1992). For many AOD-dependent
people, removal of drugs from their bodies is indeed part of the detoxification process. In the
context of treating patients who are physically dependent on alcohol or other drugs,
detoxification also includes the period of time during which the body's physiology is adjusting to
the absence of drugs. However, as Gerstein and Harwood wrote, "Detoxification . . . is not a
treatment for drug-seeking behavior. Rather, it is a family of procedures for alleviating the short-
term symptoms of withdrawal from drug dependence" (Gerstein and Harwood, 1990). It must
also include "a period of psychological readjustment designed to prepare the patient to take the
next step in ongoing treatment" (Czechowicz, 1979).
As more and more States implement health care reform, third-party payers often manage
payment for AOD detoxification services separately from other phases of drug treatment, as
though detoxification occurs in isolation from drug treatment. In clinical practice, this separation
cannot exist. Detoxification is one component of a comprehensive treatment strategy.
This TIP focuses specifically on detoxification and does not attempt to provide guidance on issues
beyond those immediately related to this subject. The panelists who developed the TIP are aware
that the discussion of detoxification, apart from the larger context of substance use disorders, is
somewhat incomplete. However, the scope of this TIP is determined by the need to cover one
issue in depth, complementing but not duplicating information available in other TIPs in the
series.
Length of Detoxification
Because detoxification often entails a more intensive level of care than other types of AOD
treatment, there is a practical value in defining a period during which a person is "in
detoxification." There is no simple way to do this. Usually, the detoxification period is defined as
the period during which the patient receives detoxification medications.
Third-party payers often manage payment for AOD detoxification services separately from other
phases of drug treatment, as though detoxification occurs in isolation from drug treatment. In
clinical practice, this separation cannot exist. Detoxification is one component of a
comprehensive treatment strategy.
Another way of defining the detoxification period is by measuring the duration of withdrawal
signs or symptoms. However, the duration of these symptoms may be difficult to determine in a
correctly medicated patient because symptoms of withdrawal are largely suppressed by the
medication. Chapter 3 describes the typical lengths of regimens for withdrawal.
The Role of Detoxification in AOD Abuse Treatment
For many AOD-dependent patients, detoxification is the beginning phase of treatment. It can
entail more than a period of physical readjustment. It can also be a time when patients begin to
make the psychological readjustments necessary for ongoing treatment. Offering detoxification
alone, without followup to an appropriate level of care, is an inadequate use of limited resources.
People who have severe problems that predate their AOD dependence or addiction -- such as
family disintegration, lack of job skills, illiteracy, or psychiatric disorders -- may continue to have
these problems after detoxification unless specific services are available to help them deal with
these factors (Gerstein and Harwood, 1990).
Immediate Goals of Detoxification
To provide a safe withdrawal from the drug(s) of dependence and
enable the patient to become drug free. Many risks are associated
with withdrawal, some influenced by the setting. For persons who are
severely dependent on alcohol, abrupt, unsupervised cessation of drinking
may result in delirium tremens or death. Other sedative-hypnotics may
produce life-threatening withdrawal syndromes. Withdrawal from opioids
produces severe discomfort, but is not generally life threatening. However,
risks to the patient and society are not limited to the severity of the
patient's physical disturbance, particularly when the detoxification is
conducted in an outpatient setting. Outpatients experiencing withdrawal
symptoms may self-medicate with street drugs. The resulting interaction
between prescribed medication and street drugs may result in an
overdose. Less severe side effects include sedation or a drop in blood
pressure.
To provide withdrawal that is humane and protects the patient's
dignity. A caring staff, a supportive environment, sensitivity to cultural